A citation-based method for searching scientific literature

Vicneswarry Dorairaj, Siti Aishah Sulaiman, Nadiah Abu, Nor Azian Abdul Murad. Biomedicines 2021
Times Cited: 7







List of co-cited articles
14 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


NAFLD: a multisystem disease.
Christopher D Byrne, Giovanni Targher. J Hepatol 2015
28


Global epidemiology of nonalcoholic fatty liver disease-Meta-analytic assessment of prevalence, incidence, and outcomes.
Zobair M Younossi, Aaron B Koenig, Dinan Abdelatif, Yousef Fazel, Linda Henry, Mark Wymer. Hepatology 2016
28

MicroRNAs in the Pathogenesis of Nonalcoholic Fatty Liver Disease.
Zhiqiang Fang, Guorui Dou, Lin Wang. Int J Biol Sci 2021
13
28

Nuclear Receptors Linking Metabolism, Inflammation, and Fibrosis in Nonalcoholic Fatty Liver Disease.
Tobias Puengel, Hanyang Liu, Adrien Guillot, Felix Heymann, Frank Tacke, Moritz Peiseler. Int J Mol Sci 2022
16
28

Nonalcoholic Fatty Liver Disease and Endocrine Axes-A Scoping Review.
Madalena Von-Hafe, Marta Borges-Canha, Catarina Vale, Ana Rita Leite, João Sérgio Neves, Davide Carvalho, Adelino Leite-Moreira. Metabolites 2022
9
28



A new definition for metabolic dysfunction-associated fatty liver disease: An international expert consensus statement.
Mohammed Eslam, Philip N Newsome, Shiv K Sarin, Quentin M Anstee, Giovanni Targher, Manuel Romero-Gomez, Shira Zelber-Sagi, Vincent Wai-Sun Wong, Jean-François Dufour, Jörn M Schattenberg,[...]. J Hepatol 2020
28

Nonalcoholic Fatty Liver Disease 2020: The State of the Disease.
Thomas G Cotter, Mary Rinella. Gastroenterology 2020
339
28

Modeling the epidemic of nonalcoholic fatty liver disease demonstrates an exponential increase in burden of disease.
Chris Estes, Homie Razavi, Rohit Loomba, Zobair Younossi, Arun J Sanyal. Hepatology 2018
905
28

MAFLD: A Consensus-Driven Proposed Nomenclature for Metabolic Associated Fatty Liver Disease.
Mohammed Eslam, Arun J Sanyal, Jacob George. Gastroenterology 2020
28

Circulating microRNA signature in non-alcoholic fatty liver disease: from serum non-coding RNAs to liver histology and disease pathogenesis.
Carlos J Pirola, Tomas Fernández Gianotti, Gustavo O Castaño, Pablo Mallardi, Julio San Martino, María Mora Gonzalez Lopez Ledesma, Diego Flichman, Faridodin Mirshahi, Arun J Sanyal, Silvia Sookoian. Gut 2015
353
28

Peroxisome Proliferator-Activated Receptors and Their Novel Ligands as Candidates for the Treatment of Non-Alcoholic Fatty Liver Disease.
Anne Fougerat, Alexandra Montagner, Nicolas Loiseau, Hervé Guillou, Walter Wahli. Cells 2020
40
28

S-equol, a potent ligand for estrogen receptor beta, is the exclusive enantiomeric form of the soy isoflavone metabolite produced by human intestinal bacterial flora.
Kenneth D R Setchell, Carlo Clerici, Edwin D Lephart, Sidney J Cole, Claire Heenan, Danilo Castellani, Brian E Wolfe, Linda Nechemias-Zimmer, Nadine M Brown, Trent D Lund,[...]. Am J Clin Nutr 2005
290
14


Association of non-alcoholic fatty liver disease with chronic kidney disease: a systematic review and meta-analysis.
Giovanni Musso, Roberto Gambino, James H Tabibian, Mattias Ekstedt, Stergios Kechagias, Masahide Hamaguchi, Rolf Hultcrantz, Hannes Hagström, Seung Kew Yoon, Phunchai Charatcharoenwitthaya,[...]. PLoS Med 2014
380
14

Estrogen Signals Through Peroxisome Proliferator-Activated Receptor-γ Coactivator 1α to Reduce Oxidative Damage Associated With Diet-Induced Fatty Liver Disease.
Aurèle Besse-Patin, Mélissa Léveillé, Daniel Oropeza, Bich N Nguyen, Annik Prat, Jennifer L Estall. Gastroenterology 2017
83
14

Prevalence and risk factors of non-alcoholic fatty liver disease in the elderly: results from the Rotterdam study.
Edith M Koehler, Jeoffrey N L Schouten, Bettina E Hansen, Frank J A van Rooij, Albert Hofman, Bruno H Stricker, Harry L A Janssen. J Hepatol 2012
145
14

Inadequate Physical Activity and Sedentary Behavior Are Independent Predictors of Nonalcoholic Fatty Liver Disease.
Donghee Kim, Luis Miguel Vazquez-Montesino, Andrew A Li, George Cholankeril, Aijaz Ahmed. Hepatology 2020
34
14


Insights into the Epidemiology, Pathogenesis, and Therapeutics of Nonalcoholic Fatty Liver Diseases.
Yao Yu, Jingjing Cai, Zhigang She, Hongliang Li. Adv Sci (Weinh) 2018
77
14

Urinary isoflavone concentrations are inversely associated with cardiometabolic risk markers in pregnant U.S. women.
Ling Shi, Heather Harker Ryan, Emily Jones, Tiffany A Moore Simas, Alice H Lichtenstein, Qi Sun, Laura L Hayman. J Nutr 2014
24
14

Overnight urinary isoflavone excretion in a population of women living in the United States, and its relationship to isoflavone intake.
Charlotte Atkinson, Heather E Skor, E Dawn Fitzgibbons, Delia Scholes, Chu Chen, Kristiina Wähälä, Stephen M Schwartz, Johanna W Lampe. Cancer Epidemiol Biomarkers Prev 2002
60
14

Genistein has beneficial effects on hepatic steatosis in high fat-high sucrose diet-treated rats.
Huanhuan Liu, Huijia Zhong, Yimin Yin, Zhuoqin Jiang. Biomed Pharmacother 2017
29
14

Association of nonalcoholic fatty liver disease (NAFLD) with hepatocellular carcinoma (HCC) in the United States from 2004 to 2009.
Zobair M Younossi, Munkhzul Otgonsuren, Linda Henry, Chapy Venkatesan, Alita Mishra, Madeline Erario, Sharon Hunt. Hepatology 2015
467
14


Epidemiology and natural history of non-alcoholic steatohepatitis.
Curtis K Argo, Stephen H Caldwell. Clin Liver Dis 2009
276
14

Characterization of hepatocellular carcinoma (HCC) in non-alcoholic fatty liver disease (NAFLD) patients without cirrhosis.
Bashar Mohamad, Vaishal Shah, Mykola Onyshchenko, Mohammed Elshamy, Federico Aucejo, Rocio Lopez, Ibrahim A Hanouneh, Razan Alhaddad, Naim Alkhouri. Hepatol Int 2016
88
14

Bacterial metabolism as responsible of beneficial effects of phytoestrogens on human health.
Ángela Peirotén, Daniel Bravo, José M Landete. Crit Rev Food Sci Nutr 2020
20
14

Fatty infiltration of liver in hyperlipidemic patients.
N Assy, K Kaita, D Mymin, C Levy, B Rosser, G Minuk. Dig Dis Sci 2000
236
14


Hepatokines: linking nonalcoholic fatty liver disease and insulin resistance.
Ruth C R Meex, Matthew J Watt. Nat Rev Endocrinol 2017
295
14

2014 evidence-based guideline for the management of high blood pressure in adults: report from the panel members appointed to the Eighth Joint National Committee (JNC 8).
Paul A James, Suzanne Oparil, Barry L Carter, William C Cushman, Cheryl Dennison-Himmelfarb, Joel Handler, Daniel T Lackland, Michael L LeFevre, Thomas D MacKenzie, Olugbenga Ogedegbe,[...]. JAMA 2014
14

Effects of Dietary Phytoestrogens on Hormones throughout a Human Lifespan: A Review.
Inés Domínguez-López, Maria Yago-Aragón, Albert Salas-Huetos, Anna Tresserra-Rimbau, Sara Hurtado-Barroso. Nutrients 2020
35
14


Serum lipids mediate the relationship of multiple polyaromatic hydrocarbons on non-alcoholic fatty liver disease: A population-based study.
Zhengyu Hu, Yan Li, Yuexin Yang, Weidi Yu, Wangcheng Xie, Guodong Song, Yaqin Qian, Zhenshun Song. Sci Total Environ 2021
6
16

Genistein supplementation improves insulin resistance and inflammatory state in non-alcoholic fatty liver patients: A randomized, controlled trial.
Sasan Amanat, Mohammad Hassan Eftekhari, Mohammad Fararouei, Kamran Bagheri Lankarani, Seyed Jalil Massoumi. Clin Nutr 2018
52
14


The effect of enterolactone on sphingolipid pathway and hepatic insulin resistance development in HepG2 cells.
Tomasz Charytoniuk, Nicoletta Iłowska, Klaudia Berk, Krzysztof Drygalski, Adrian Chabowski, Karolina Konstantynowicz-Nowicka. Life Sci 2019
13
14

Hypocholesterolemic Efficacy of Secoisolariciresinol Diglucoside and Its Polymer in Rat.
Yajia Guo, Xiaolei Yang, Timothy J Tse, Sarah K Purdy, Rana Mustafa, Jianheng Shen, Jane Alcorn, Martin J T Reaney. J Nat Prod 2021
4
25


Bioavailability of lignans in human subjects.
Thomas Clavel, Joël Doré, Michael Blaut. Nutr Res Rev 2006
62
14

Gut bacterial metabolism of the soy isoflavone daidzein: exploring the relevance to human health.
Charlotte Atkinson, Cara L Frankenfeld, Johanna W Lampe. Exp Biol Med (Maywood) 2005
349
14

Prevalence and associated factors of non-alcoholic fatty liver disease in patients with type-2 diabetes mellitus.
Nathalie C Leite, Gil F Salles, Antonio L E Araujo, Cristiane A Villela-Nogueira, Claudia R L Cardoso. Liver Int 2009
349
14

The association between urinary phytoestrogen excretion and components of the metabolic syndrome in NHANES.
Tristan Struja, Aline Richard, Jakob Linseisen, Monika Eichholzer, Sabine Rohrmann. Eur J Nutr 2014
20
14

(-)-Secoisolariciresinol attenuates high-fat diet-induced obesity in C57BL/6 mice.
Shiori Tominaga, Kosuke Nishi, Sogo Nishimoto, Koichi Akiyama, Satoshi Yamauchi, Takuya Sugahara. Food Funct 2012
10
14

The natural history of non-alcoholic fatty liver disease.
Stephen Caldwell, Curtis Argo. Dig Dis 2010
120
14

Metabolic impact of estrogen signalling through ERalpha and ERbeta.
Anna Foryst-Ludwig, Ulrich Kintscher. J Steroid Biochem Mol Biol 2010
112
14

Flaxseed lignan attenuates high-fat diet-induced fat accumulation and induces adiponectin expression in mice.
S Fukumitsu, K Aida, N Ueno, S Ozawa, Y Takahashi, M Kobori. Br J Nutr 2008
72
14


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.